Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Withdrawal of inhaled glucocorticoids and exacerbations of COPD.
Magnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, Towse L, Finnigan H, Dahl R, Decramer M, Chanez P, Wouters EF, Calverley PM; WISDOM Investigators. Magnussen H, et al. Among authors: calverley pm. N Engl J Med. 2014 Oct 2;371(14):1285-94. doi: 10.1056/NEJMoa1407154. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25196117 Free article. Clinical Trial.
Inhaled glucocorticoids and COPD exacerbations.
Magnussen H, Tetzlaff K, Calverley PM. Magnussen H, et al. Among authors: calverley pm. N Engl J Med. 2015 Jan 1;372(1):93-4. doi: 10.1056/NEJMc1413308. N Engl J Med. 2015. PMID: 25551535 Free article. No abstract available.
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
Watz H, Tetzlaff K, Wouters EF, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, Disse B, Finnigan H, Calverley PM. Watz H, et al. Among authors: calverley pm. Lancet Respir Med. 2016 May;4(5):390-8. doi: 10.1016/S2213-2600(16)00100-4. Epub 2016 Apr 7. Lancet Respir Med. 2016. PMID: 27066739 Clinical Trial.
Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.
Magnussen H, Tetzlaff K, Bateman ED, Watz H, Kirsten AM, Wouters EF, Disse B, Finnigan H, Rodriguez-Roisin R, Calverley PM. Magnussen H, et al. Among authors: calverley pm. Eur Respir J. 2016 Feb;47(2):651-4. doi: 10.1183/13993003.01644-2015. Epub 2015 Nov 19. Eur Respir J. 2016. PMID: 26585433 Free article. Clinical Trial. No abstract available.
Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease.
Rodriguez-Roisin R, Tetzlaff K, Watz H, Wouters EF, Disse B, Finnigan H, Magnussen H, Calverley PM. Rodriguez-Roisin R, et al. Among authors: calverley pm. Int J Chron Obstruct Pulmon Dis. 2016 Aug 22;11:1973-81. doi: 10.2147/COPD.S106142. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27578972 Free PMC article. Clinical Trial.
Tiotropium Respimat inhaler and the risk of death in COPD.
Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators. Wise RA, et al. N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30. N Engl J Med. 2013. PMID: 23992515 Free article. Clinical Trial.
Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study.
Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, Smith C, Man WD, Tal-Singer R, Edwards LD, Calverley PM, Magnussen H, Polkey MI, Wouters EF. Waschki B, et al. Among authors: calverley pm. Respir Med. 2012 Apr;106(4):522-30. doi: 10.1016/j.rmed.2011.10.022. Epub 2011 Nov 25. Respir Med. 2012. PMID: 22118987 Free article.
461 results